Document Detail


Prostate Cancer Detection in Patients With Total Serum Prostate-Specific Antigen Levels of 4-10 ng/mL: Diagnostic Efficacy of Diffusion-Weighted Imaging, Dynamic Contrast-Enhanced MRI, and T2-Weighted Imaging.
MedLine Citation:
PMID:  21862809     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: The purpose of this study is to evaluate the utility of T2-weighted imaging, dynamic contrast-enhanced MRI (DCE-MRI), and diffusion-weighted imaging (DWI) for detecting prostate cancer in patients with total serum prostate-specific antigen (PSA) levels of 4-10 ng/mL, which is referred to as the "gray zone."
MATERIALS AND METHODS: Fifty patients with gray-zone PSA levels underwent MRI before biopsy. According to the sites of biopsy, the prostate was divided into eight regions on MRI scans. These regions were evaluated individually for the following features: detectability of prostate cancer on per-region and per-patient bases, and relationship between tumor size and positive or negative MRI findings for tumor detection.
RESULTS: On a per-region basis, the sensitivity and specificity of tumor detection were 36% and 97% for T2-weighted imaging, 43% and 95% for DCE-MRI, 38% and 96% for DWI, and 53% and 93% for the combined method of MRI, respectively. The sensitivity of combined MRI to detect tumor was significantly higher than those of the individual methods (p < 0.001 to p = 0.001). Tumor size was significantly larger in regions with positive MRI findings than in regions with negative MRI findings (p = 0.004). On a per-patient basis, sensitivity and specificity of combined MRI to detect prostate cancer were 83% and 80%, respectively.
CONCLUSION: Combined T2-weighted imaging, DWI, and DCE-MRI findings appear to be potentially useful for detecting and managing prostate cancer, even when performed for patients with gray-zone PSA levels.
Authors:
Tsutomu Tamada; Teruki Sone; Hiroki Higashi; Yoshimasa Jo; Akira Yamamoto; Akihiko Kanki; Katsuyoshi Ito
Related Documents :
21892279 - Integrated fdg pet/ct: utility and applications in clinical oncology.
11962189 - Computed tomogram prior to prostatectomy. advantage in defining planning target volumes...
21745689 - Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser abla...
17923739 - A magnetic resonance-based seed localization method for i-125 prostate implants.
11163519 - Patient positioning using detailed three-dimensional surface data for patients undergoi...
19605659 - Imaging of the seminal vesicle and vas deferens.
10682769 - Ct and mr imaging findings of bowel ischemia from various primary causes.
2701699 - Magnetic resonance imaging of tumors of the upper aerodigestive tract.
1438669 - Bilateral paramedian thalamic infarction: a distinct but poorly recognized stroke syndr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  AJR. American journal of roentgenology     Volume:  197     ISSN:  1546-3141     ISO Abbreviation:  AJR Am J Roentgenol     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-08-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7708173     Medline TA:  AJR Am J Roentgenol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  664-70     Citation Subset:  AIM; IM    
Affiliation:
Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama 701-0192, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risk of nephrogenic systemic fibrosis in liver transplantation patients.
Next Document:  Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency a...